Literature DB >> 22311569

A contemporary assessment of the risk for sudden cardiac death in patients with congenital heart disease.

Michael J Silka1, Yaniv Bar-Cohen.   

Abstract

Assessment of the risk for sudden cardiac death (SCD) after surgery for congenital heart disease (CHD) remains a difficult challenge. In the study of this problem, the focus has evolved from concern regarding late-onset heart block to a subsequent focus on ventricular and reentrant atrial arrhythmias, with the most recent emphasis on ventricular dysfunction and heart failure. Sudden cardiac death in CHD patients has been studied most extensively in tetralogy of Fallot. More than 30 risk factors have been proposed, with age at repair, QRS duration, right ventricular enlargement, and left ventricular dysfunction considered the most predictive risk factors. Additionally, SCD has been studied in patients with atrial repair for transposition of the great arteries, left heart obstructive lesions, and to a limited extent, patients with univentricular physiology. This review discusses current risk factors for SCD in CHD and the limited positive predictive value of any individual factor. The emphasis is on contemporary patients with CHD, who differ markedly from those who had repair of CHD decades earlier. This is characterized by complete repairs during the neonatal period, improved physiologic outcomes, and extended survival of patients with complex forms of CHD. Therefore, earlier data and conclusions may not be relevant to newer generations of patients with CHD. According to current perspectives, systemic ventricular dysfunction becomes a major risk factor beyond the age of 20 years. The first symptomatic arrhythmia may result in SCD, and defibrillators are increasingly implanted despite the lack of risk stratification criteria. The large number of potential risk factors and therapeutic options, in contrast to the low incidence of actual events, results in a difficult clinical challenge in the assessment of the risk for SCD in the individual patient with CHD.

Entities:  

Mesh:

Year:  2012        PMID: 22311569     DOI: 10.1007/s00246-012-0165-3

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  52 in total

Review 1.  Interventional electrophysiology in patients with congenital heart disease.

Authors:  Edward P Walsh
Journal:  Circulation       Date:  2007-06-26       Impact factor: 29.690

2.  Risk stratification for primary implantation of a cardioverter-defibrillator in patients with ischemic left ventricular dysfunction.

Authors:  Ilan Goldenberg; Anant K Vyas; W Jackson Hall; Arthur J Moss; Hongyue Wang; Hua He; Wojciech Zareba; Scott McNitt; Mark L Andrews
Journal:  J Am Coll Cardiol       Date:  2008-01-22       Impact factor: 24.094

3.  Catheter ablation in transposition of the great arteries with Mustard or Senning baffles.

Authors:  Paul Khairy; George F Van Hare
Journal:  Heart Rhythm       Date:  2008-11-27       Impact factor: 6.343

4.  Sudden death among postoperative patients with tetralogy of Fallot: a follow-up study of 243 patients for an average of twelve years.

Authors:  T G Quattlebaum; J Varghese; C A Neill; J S Donahoo
Journal:  Circulation       Date:  1976-08       Impact factor: 29.690

5.  Outcome of listing for cardiac transplantation for failed Fontan: a multi-institutional study.

Authors:  D Bernstein; D Naftel; C Chin; L J Addonizio; P Gamberg; E D Blume; D Hsu; C E Canter; J K Kirklin; W R Morrow
Journal:  Circulation       Date:  2006-07-17       Impact factor: 29.690

6.  Cardiac rhythm after the Mustard operation for complete transposition of the great arteries.

Authors:  C J Flinn; G S Wolff; M Dick; R M Campbell; G Borkat; A Casta; A Hordof; T J Hougen; R E Kavey; J Kugler
Journal:  N Engl J Med       Date:  1984-06-21       Impact factor: 91.245

7.  Mechanoelectrical interaction in tetralogy of Fallot. QRS prolongation relates to right ventricular size and predicts malignant ventricular arrhythmias and sudden death.

Authors:  M A Gatzoulis; J A Till; J Somerville; A N Redington
Journal:  Circulation       Date:  1995-07-15       Impact factor: 29.690

8.  Sudden death prior to pediatric heart transplantation: would implantable defibrillators improve outcome?

Authors:  Edward K Rhee; Charles E Canter; Susan Basile; Steven A Webber; David C Naftel
Journal:  J Heart Lung Transplant       Date:  2007-05       Impact factor: 10.247

Review 9.  Should patients with congenital heart disease and a systemic ventricular ejection fraction less than 30% undergo prophylactic implantation of an ICD? Patients with congenital heart disease and a systemic ventricular ejection fraction less than 30% should undergo prophylactic implantation of an implantable cardioverter defibrillator.

Authors:  Michael J Silka; Yaniv Bar-Cohen
Journal:  Circ Arrhythm Electrophysiol       Date:  2008-10

10.  Identification and ablation of macroreentrant ventricular tachycardia with the CARTO electroanatomical mapping system.

Authors:  W G Stevenson; E Delacretaz; P L Friedman; K E Ellison
Journal:  Pacing Clin Electrophysiol       Date:  1998-07       Impact factor: 1.976

View more
  10 in total

Review 1.  Arrhythmias in structural heart disease.

Authors:  H Sawyer Gillespie; Charles C H Lin; Jordan M Prutkin
Journal:  Curr Cardiol Rep       Date:  2014-08       Impact factor: 2.931

2.  Physical activity recommendations for patients with electrophysiologic and structural congenital heart disease: a survey of Canadian health care providers.

Authors:  Thomas M Roston; Astrid M De Souza; George G S Sandor; Shubhayan Sanatani; James E Potts
Journal:  Pediatr Cardiol       Date:  2013-02-23       Impact factor: 1.655

3.  An Imaging Protocol to Discriminate Specialized Conduction Tissue During Congenital Heart Surgery.

Authors:  Abhijit Mondal; John Lackey; Mossab Saeed; Fei-Yi Wu; Jordan K Johnson; Chao Huang; Frank B Sachse; Robert Hitchcock; Aditya K Kaza
Journal:  Semin Thorac Cardiovasc Surg       Date:  2019-02-06

4.  Novel GATA6 mutations associated with congenital ventricular septal defect or tetralogy of fallot.

Authors:  Juan Wang; Xue-Jiao Luo; Yuan-Feng Xin; Yi Liu; Zhong-Min Liu; Qian Wang; Ruo-Gu Li; Wei-Yi Fang; Xiao-Zhou Wang; Yi-Qing Yang
Journal:  DNA Cell Biol       Date:  2012-09-28       Impact factor: 3.311

5.  The clinical characteristics of sudden cardiac arrest in asymptomatic patients with congenital heart disease.

Authors:  Aya Miyazaki; Heima Sakaguchi; Hideo Ohuchi; Kenji Yasuda; Nobuyuki Tsujii; Michio Matsuoka; Tetsuya Yamamoto; Satoshi Yazaki; Etsuko Tsuda; Osamu Yamada
Journal:  Heart Vessels       Date:  2013-11-27       Impact factor: 2.037

6.  GATA5 loss-of-function mutation responsible for the congenital ventriculoseptal defect.

Authors:  Dong Wei; Han Bao; Ning Zhou; Gui-Fen Zheng; Xing-Yuan Liu; Yi-Qing Yang
Journal:  Pediatr Cardiol       Date:  2012-09-09       Impact factor: 1.655

7.  Management of late arrhythmias in adults with repaired congenital heart disease.

Authors:  Jennifer H Huang; Seshadri Balaji
Journal:  Curr Treat Options Cardiovasc Med       Date:  2013-10

8.  Prevalence and spectrum of PITX2c mutations associated with congenital heart disease.

Authors:  Juan Wang; Yuan-Feng Xin; Wen-Jun Xu; Zhong-Min Liu; Xing-Biao Qiu; Xin-Kai Qu; Lei Xu; Xin Li; Yi-Qing Yang
Journal:  DNA Cell Biol       Date:  2013-10-01       Impact factor: 3.311

9.  GATA5 loss-of-function mutations underlie tetralogy of fallot.

Authors:  Dong Wei; Han Bao; Xing-Yuan Liu; Ning Zhou; Qian Wang; Ruo-Gu Li; Ying-Jia Xu; Yi-Qing Yang
Journal:  Int J Med Sci       Date:  2012-12-10       Impact factor: 3.738

10.  PITX2c loss-of-function mutations responsible for congenital atrial septal defects.

Authors:  Fang Yuan; Lan Zhao; Juan Wang; Wei Zhang; Xin Li; Xing-Biao Qiu; Ruo-Gu Li; Ying-Jia Xu; Lei Xu; Xing-Kai Qu; Wei-Yi Fang; Yi-Qing Yang
Journal:  Int J Med Sci       Date:  2013-08-22       Impact factor: 3.738

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.